Therefore, it would be interesting to characterize the expression of ZMIZ1 and different length polyQ AR in patient samples of prostate cancer, AIS, and other human disorders that may be closely related to either loss or gain-of-function mutations in the AR gene. Here, AR is linked to Familial prostate cancer.